Health Care

Suppliers invest in R&D, distribution and brand marketing

The OTC (over-the-counter) market continued to expand, with vitamins and mineral supplements experiencing the strongest growth.

Major health care companies invested heavily in R&D, acquisitions, supply chains and distribution networks.

Corporate transactions included two major joint ventures: Simcere and Merck in Shanghai; and Zhejiang Hisun and Pfizer. In addition, Shanghai Fosun Pharmaceutical (Group) Company became the largest single shareholder of US-based medical care company Saladax Biomedical Inc. And China Kanghui Holdings, a maker of orthopedic devices, was acquired by the US medical technology company, Medtronic. CR Sanjiu purchased Shandong Huawei Medical, a traditional Chinese medicine provider.

Trust and the need for need for product reliability remained a key challenge for OTC suppliers. Marketing campaigns aimed at strengthening consumer confidence. The brand value of the health care category grew 67 percent in the BrandZ™ ranking. Macro trends, including health care reform and the aging of the population, are expected to sustain category sales growth.

BrandZ China Top 100 2014

BrandZ China 2014 Report Top 100 Report
English | Chinese

Top 100 Chart
English | Chinese

2014 BrandZ China Top 100 Infographic

BrandZ China 2014 Infographic

Methodology and valuation by Kantar Millward Brown

Contact Us